Prediction for Plasma Trough Concentration and Optimal Dosing of Imatinib under Multiple Clinical Situations Using Physiologically Based Pharmacokinetic Modeling.

Gao, Dongmei; Wang, Guopeng; Wu, Honghai; Wu, JinHua; Zhao, Xiaoang

Gao, Dongmei; Wang, Guopeng; Wu, Honghai; Wu, JinHua; Zhao, Xiaoang.

Afiliação

Gao D; Department of Medical Oncology, Bethune International Peace Hospital, Shijiazhuang 050082, China.
Wang G; Zhongcai Health (Beijing) Biological Technology Development Co., Ltd., Beijing 101500, China.
Wu H; Department of Clinical Pharmacy, Bethune International Peace Hospital, Shijiazhuang 050082, China.
Wu J; Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China.
Zhao X; Institute of Chinese Material Medica China Academy of Chinese Medical Sciences, Beijing 100700, China.

ACS Omega ; 8(15): 13741-13753, 2023 Apr 18.

Article em En | MEDLINE | ID: mdl-37091368

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: ACS Omega Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google